• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症与静脉血栓栓塞风险:基于人群的队列研究。

Multiple sclerosis and risk of venous thromboembolism: a population-based cohort study.

机构信息

Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.

出版信息

Neuroepidemiology. 2012;38(2):76-83. doi: 10.1159/000335496. Epub 2012 Jan 27.

DOI:10.1159/000335496
PMID:22286104
Abstract

BACKGROUND

Multiple sclerosis (MS) patients may be at increased risk of venous thromboembolism (VTE), but evidence is limited.

OBJECTIVES

To examine long-term risk of VTE among MS patients.

PATIENTS AND METHODS

We conducted a population-based cohort study among 17,418 Danish MS patients and 87,090 comparison cohort members from the general population. Data on MS, VTE and comorbidities were obtained from the Danish National Registry of Patients including all admissions to Danish hospitals since 1977. We computed cumulative risks for VTE and adjusted incidence rate ratios (IRRs).

RESULTS

A total of 34 (0.2%) MS patients and 36 (0.04%) comparison cohort members had a deep venous thrombosis (DVT) within 1 year following the date of initial MS diagnosis/index date [adjusted IRR = 3.02 (95% CI: 2.14-4.27)]. During this period, 16 (0.09%) MS patients and 26 (0.03%) comparison cohort members had a documented pulmonary embolism (PE) [adjusted IRR = 2.85 (95% CI: 1.72-4.70)]. During the subsequent up to 29 years, 315 (1.9% of MS patients alive at year 1) MS patients had a record of a DVT [adjusted IRR = 2.28 (95% CI: 2.01-2.59)] and 129 (0.8%) had PE [IRR = 1.58 (95% CI: 1.31-1.92].

CONCLUSION

MS is a risk factor for VTE, but the absolute risk is low.

摘要

背景

多发性硬化症(MS)患者发生静脉血栓栓塞症(VTE)的风险可能会增加,但证据有限。

目的

研究 MS 患者发生 VTE 的长期风险。

患者和方法

我们在丹麦开展了一项基于人群的队列研究,共纳入 17418 名 MS 患者和 87090 名来自普通人群的对照组成员。MS、VTE 和合并症的数据来自丹麦国家患者登记处,包括自 1977 年以来所有在丹麦医院的住院记录。我们计算了 VTE 的累积风险,并调整了发病率比(IRR)。

结果

在初始 MS 诊断/索引日期后 1 年内,共有 34 名(0.2%)MS 患者和 36 名(0.04%)对照组成员发生深静脉血栓形成(DVT)[调整后的 IRR=3.02(95%CI:2.14-4.27)]。在此期间,16 名(0.09%)MS 患者和 26 名(0.03%)对照组成员有记录的肺栓塞(PE)[调整后的 IRR=2.85(95%CI:1.72-4.70)]。在随后的 29 年中,315 名(1 年后存活的 MS 患者的 1.9%)MS 患者有 DVT 记录[调整后的 IRR=2.28(95%CI:2.01-2.59)],129 名(0.8%)有 PE[IRR=1.58(95%CI:1.31-1.92)]。

结论

MS 是 VTE 的一个危险因素,但绝对风险较低。

相似文献

1
Multiple sclerosis and risk of venous thromboembolism: a population-based cohort study.多发性硬化症与静脉血栓栓塞风险:基于人群的队列研究。
Neuroepidemiology. 2012;38(2):76-83. doi: 10.1159/000335496. Epub 2012 Jan 27.
2
Body height and sex-related differences in incidence of venous thromboembolism: a Danish follow-up study.人体身高与静脉血栓栓塞发生率的性别差异:一项丹麦随访研究。
Eur J Intern Med. 2010 Aug;21(4):268-72. doi: 10.1016/j.ejim.2010.03.013. Epub 2010 Apr 28.
3
The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study.炎症性肠病患者深静脉血栓形成和肺栓塞的发病率:一项基于人群的队列研究。
Thromb Haemost. 2001 Mar;85(3):430-4.
4
Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study.丹麦炎症性肠病儿童和成人的血栓栓塞风险:一项基于人群的全国性研究。
Gut. 2011 Jul;60(7):937-43. doi: 10.1136/gut.2010.228585. Epub 2011 Feb 21.
5
Prospective analysis of risk factors and distribution of venous thromboembolism in the population-based Malmö Thrombophilia Study (MATS).基于人群的马尔默血栓形成倾向研究(MATS)中静脉血栓栓塞的风险因素和分布的前瞻性分析。
Thromb Res. 2009 Dec;124(6):663-6. doi: 10.1016/j.thromres.2009.04.022. Epub 2009 Jun 3.
6
Superficial and deep venous thrombosis, pulmonary embolism and subsequent risk of cancer.浅静脉血栓和深静脉血栓、肺栓塞及随后的癌症风险。
Eur J Cancer. 2012 Mar;48(4):586-93. doi: 10.1016/j.ejca.2011.10.032. Epub 2011 Nov 28.
7
Global Risk Profile Verification in Patients with Venous Thromboembolism (GRIP VTE) in 5 Gulf countries.海湾地区5个国家静脉血栓栓塞症患者的全球风险概况验证(GRIP VTE)
Clin Appl Thromb Hemost. 2009 May-Jun;15(3):289-96. doi: 10.1177/1076029608315168. Epub 2008 Apr 8.
8
Atrial fibrillation associated with increased risk of venous thromboembolism. A population-based cohort study.心房颤动与静脉血栓栓塞风险增加相关。一项基于人群的队列研究。
Thromb Haemost. 2015 Jan;113(1):185-92. doi: 10.1160/TH14-05-0405. Epub 2014 Oct 16.
9
Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE Registry.预测癌症合并静脉血栓栓塞患者的复发或大出血。RIETE注册研究的结果。
Thromb Haemost. 2008 Sep;100(3):435-9.
10
Rates of venous thromboembolism occurrence in medical patients among the insured population.参保人群中医疗患者静脉血栓栓塞症发生率。
Thromb Haemost. 2009 Nov;102(5):951-7. doi: 10.1160/TH09-02-0073.

引用本文的文献

1
Transient Bilateral Atrial Thrombi in a Patient With Multiple Sclerosis and Massive Pulmonary Embolism: A Case Report and Review of the Literature.一名患有多发性硬化症和大面积肺栓塞患者的短暂性双侧心房血栓:病例报告及文献复习
Cureus. 2025 Jul 15;17(7):e87998. doi: 10.7759/cureus.87998. eCollection 2025 Jul.
2
Targeting Vascular Impairment, Neuroinflammation, and Oxidative Stress Dynamics with Whole-Body Cryotherapy in Multiple Sclerosis Treatment.全身性低温疗法治疗多发性硬化症:靶向血管损伤、神经炎症和氧化应激动态。
Int J Mol Sci. 2024 Mar 29;25(7):3858. doi: 10.3390/ijms25073858.
3
Pathogenic Role of Fibrinogen in the Neuropathology of Multiple Sclerosis: A Tale of Sorrows and Fears.
纤维蛋白原在多发性硬化症神经病理学中的致病作用:一个充满悲伤和恐惧的故事。
Neurochem Res. 2023 Nov;48(11):3255-3269. doi: 10.1007/s11064-023-03981-1. Epub 2023 Jul 13.
4
Multiple sclerosis and the incidence of venous thromboembolism: a systematic review and meta-analysis.多发性硬化症与静脉血栓栓塞症的发病率:系统评价和荟萃分析。
J Thromb Thrombolysis. 2023 Oct;56(3):463-473. doi: 10.1007/s11239-023-02848-0. Epub 2023 Jul 2.
5
Platelet Inhibition by Low-Dose Acetylsalicylic Acid Reduces Neuroinflammation in an Animal Model of Multiple Sclerosis.低剂量乙酰水杨酸抑制血小板活化可减轻多发性硬化动物模型的神经炎症。
Int J Mol Sci. 2021 Sep 14;22(18):9915. doi: 10.3390/ijms22189915.
6
The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis.严重急性呼吸综合征冠状病毒 2 感染对多发性硬化症中神经退行性变发展的影响。
Int J Mol Sci. 2021 Feb 11;22(4):1804. doi: 10.3390/ijms22041804.
7
Increased Pro-Thrombotic Platelet Activity Associated with Thrombin/PAR1-Dependent Pathway Disorder in Patients with Secondary Progressive Multiple Sclerosis.继发性进展型多发性硬化症患者存在凝血酶/PAR1 依赖性通路障碍相关的促血栓形成血小板活性增强。
Int J Mol Sci. 2020 Oct 19;21(20):7722. doi: 10.3390/ijms21207722.
8
Metformin as a Potential Agent in the Treatment of Multiple Sclerosis.二甲双胍作为治疗多发性硬化症的潜在药物。
Int J Mol Sci. 2020 Aug 19;21(17):5957. doi: 10.3390/ijms21175957.
9
Serious safety events in rituximab-treated multiple sclerosis and related disorders.利妥昔单抗治疗多发性硬化症及相关疾病的严重安全事件。
Ann Clin Transl Neurol. 2020 Sep;7(9):1477-1487. doi: 10.1002/acn3.51136. Epub 2020 Aug 6.
10
Oxidative Damage of Blood Platelets Correlates with the Degree of Psychophysical Disability in Secondary Progressive Multiple Sclerosis.血小板氧化损伤与继发性进展型多发性硬化症的身心残疾程度相关。
Oxid Med Cell Longev. 2020 Jun 17;2020:2868014. doi: 10.1155/2020/2868014. eCollection 2020.